23andMe wants to go private. It's the latest in a line of failed SPACs

Like BuzzFeed and Virgin Galactic, the DNA-testing powerhouse is another company with a buzzy SPAC debut whose stock fell to under $1 in recent weeks. Like ... Read more

Bron:

Fast Company